Novartis to shut U.S. generics plant, cut 450 jobs

ZURICH (Reuters) - Swiss drugmaker Novartis is to cut 450 jobs in the United States over the next two years as it gradually shuts a generics manufacturing plant in Colorado and discontinues some products in the face of intense price pressures.